Læknablaðið - 15.11.1989, Blaðsíða 32

356
LÆKNABLAÐIÐ
polit., Guðmundur Sverrisson læknir, Helgi
Kristbjamarson dr. med. og Kristín Þórsdóttir
B.S. aðstoðuðu við úrvinnslu gagna og
leiðréttingar.
SUMMARY
Who prescribe psychotropic drugs to outpatients?
Survey of prescriptions in Reykjavik, March 1984.
The distribution of doctors prescribing psychotropic
drugs during one month in 1984 is analysed
according to speciality and age, which drugs they
prescibed, to whom, how and in what dosage.
Psychiatrists issued only 17% of the prescriptions
to 12.3% of the patients. General practitioners
issued 55% of the prescriptions to 62.5%
of the patients. Slightly more than 85% of
the prescriptions were for tranquillizers and
hypnotics. However, only 60% of the psychiatrists’
prescriptions were for such drugs. Almost one half
of the prescriptions included other drugs along with
the psychotropics. General practitioners issued
about 55% of their prescriptions by telephone,
while psychiatrists issued only 15% of their
prescriptions in that manner. The psychiatrists
treated relatively younger people. They advised
their patients to take the drugs on an average in
larger dosages than other doctors. All other doctors
advised their patients to take on an average less
than one defined daily dosis per day.
The oldest doctors issued more prescriptions than
the younger ones for greater amount of drugs each,
but the prescribed dosis did not vary according to
age.
It would probably be possible to reduce the
consumption of tranquillizers if other doctors did
not issue more prescriptions than the psychiatrists
by telephone.
HEIMILDIR
1. Bergström K, Westerholm B. Utköp av sedativa,
hypnotika och ataraktika i Östersunds-omrádet.
Lakartidningen 1972; 69:1366-70.
2. Agenás I, Jacobsson M. Psykiska stömingar och
psykofarmaka - exempel. Sven Farm Tidskr 1980;
84:328-33.
3. Bjömdal A. Gagn eller ugagn? Forbmk av
psykofarmaka i Norge. Oslo: Gmppe for
helsetjenesteforskning: Rapport nr. 4 1983.
4. Lader M, Pétursson H. Rational Use of Anxiolytic /
Sedative Dmgs. Dmgs 1983; 25: 514-28.
5. Sigfússon S. Hlutur geðsjúkra f heilbrigðisþjónustu
annarri en geðlæknisþjónustu. Læknablaðið 1981; 67:
50-64.
6. Williams P, Gabe J. Tranquillizer Use:
Epidemiological and Sociological Aspects. f Williams
P, Wilkinson G, (eds.): The Scope of Epidemiological
Psychiatry. London: Routledge, 1989: 328-42.
7. Hemminki E. Consumption of psychotropic dmgs. I
Bmun K, (ed.): Controlling Psychotropic Dmgs. The
Nordic Experience. London: Croom Helm, 1983: 92-
106.
8. Rapport '88: Alkohol og narkotika utveklingen i
Sverige. Stockholm: CAN 1988.
9. Allgulander C. History and current status of sedative-
hypnotic dmg use and abuse. Acta Psychiatr Scand
1986; 73: 465-78.
10. Hesbacher P, Rickels K, Rial WY et al. Psychotropic
Dmg Prescription in Family Practice. Compr
Psychiatry 1976; 17: 607-15.
11. Williams P. Physical ill-health and psychotropic dmg
prescription - a review. Psychol Med 1978; 8: 683-
93.
12. Williams P, Murray J, Clare A. A longitudinal study
of psychotropic dmg prescription. Psychol Med 1982;
12:201-6.
13. Rodrigo EK, King MB, Williams P. Health of long
term benzodiazepine users. Br Med J 1988; 296: 603-
6.
14. Uhlenhuth EH, Balter MB, Lipman RS. Minor
Tranquilizers; Clinical Correlates of Use in an Urban
Population. Arch Gen Psychiatry 1978; 35: 650-5.
15. Mellinger GD, Balter MB, Manheimer DI, et
al. Psychic Distress, Life Crisis, and Use of
Psychotherapeutic Medications. Arch Gen Psychiatry
1978; 35: 1045-52.
16. Helgason T, Bjömsson J. Geðlyfjaávísanir utan
sjúkrahúsa í Reykjavík í mars 1984. Læknablaðið
1989; 75: 293-302.
17. Norusis MJ. SPSS/PC + V2.0 Base Manual SPSS Inc.
Chicago 1988; B 165-75, C 17-21.
18. Nordiska lakemedelsnámnden. Nordisk
lákemedelsstatistik 1981-1983. Uppsala: NLN
Publikation nr. 14, 1986.
19. Hollister LE, Motzenbecker FP, Degan RU.
Withdrawal reactions from chlordiazepoxide
(»Librium«). Psychopharmacologia 1961; 2:63-8.
20. Covi L, Lipman RS, Pattison JH, et al. Length of
Treatment with Anxiolytic Sedatives and Response
to Their Sudden Withdrawal. Acta Psychiatr Scand
1973; 49: 51-64.
21. Pétursson H, Lader MH. Benzodiazepine dependence.
Br J Addict 1981; 76: 133-45.
22. Lader M. Long-term benzodiazepine use and
psychological functioning. I Freedman H, Rue
Y (eds.): The benzodiazepines in current clinical
practice. London: Royal Society of Medicine 1987,
55-69.
23. Golombok S, Moodley P, Lader M. Cognitive
impairment in long-term benzodiazepine users.
Psychol Med 1988; 18: 365-74.
24. Lingjærde O. Psychopharmaca. Oslo: Tanum, 1988.
25. Blackwell B. Side effects of antidepressant dmgs. I
Hales RE, Frances AJ, (eds.): Annual Review 1987;
6: 724-45. Washington, D.C.: American Psychiatric
Press.
26. Tyrer P. Benefits and risks of benzodiazepines. I
Freeman H, Rue Y (eds.): The benzodiazepines in
current clinical practice. London: Royal Society of
Medicine, 1987:3-11.
27. Woods JH, Katz JL, Winger G. Use and Abuse of
Benzodiazepines. JAMA 1988; 260: 3476-80.
28. Mellinger GD, Balter MB, Uhlenhuth EH. Prevalence
and Correlates of the Long-term Regular Use of
Anxiolytics. JAMA 1984; 251: 375-9.